University of West Attica
Η μελέτη Bcl-2 σε πρωτοπαθές διηθητικό καρκίνωμα μαστού και η συσχέτισή του με τους κλασικούς μορφολογικούς και ανοσοφαινοτυπικούς προγνωστικούς και προβλεπτικούς δείκτες
Abstract
dc:descriptionIntroduction: Breast carcinoma is among the three most common types of cancer worldwide, including lung cancer and colon cancer. The Bcl-2 oncogene is involved in a number of malignant neoplasms, including, leukemia and lymphoma, through the regulation of the cell apoptosis process. Purpose: The main purpose of the present study is to investigate the association of Bcl-2 with prognostically important clinicopathological features, as well as with other molecular parameters of significant predictive and prognostic value for diseases and more specifically with the ER and PR receptors, along with HER-2 and Ki-67 (MIB-1) in the Greek population. Method: 100 cases of surgically removed primary breast carcinomas were collected in the pathology laboratory of Metaxa Cancer Hospital. The cases involved women who underwent mastectomy in a series of cases from November 2022 to July 2023. The surgical breast preparations obtained in the laboratory were stabilized in 10% neutral formalin and their preparation was followed according to international guidelines. Subsequently, an immunohistochemical evaluation of the 100 cases was performed with the biomarkers Bcl-2, ER and PR, HER-2 and Ki-67 and the association of Bcl-2 with clinicopathological characteristics such as tumor pT stage, lymph node pN stage, degree of histological differentiation and histological types was statistically investigated. Results: A total of 100 cases of breast cancer were studied and the immunohistochemical expression of Bcl-2 was associated with the ER-PR, HER2 and Ki67 receptors, as well as with the clinicopathological characteristics: the pT stage of the tumor, the degree of histological differentiation, the pN stage of the lymph nodes and the histological types. The associations were performed with the Fisher’s exact test or ordinal regression and odds ratio statistic test where necessary. The presence of the Bcl2 oncogene was found with a score of 3+ in 65% of the cases, negative expression in 19%, score 2+ in 12% and score 1+ in the remaining 4%. The Bcl-2 oncogene was positively and highly associated with the ER estrogen receptors (Phi=0.760, p=<0.0001). The findings of the association of the oncogene Bcl-2 with the progesterone receptors PR were similar: a positive association was found between the two specific biomarkers (Phi=0.626, p=<0.0001). While, a negative association of Bcl-2 with HER-2 was recorded (Phi=-0.350, p=<0.0001). The most frequent degree of differentiation was Grade II (62%), followed by Grade III (24%) and Grade I (14%). A statistically significant inverse association was detected between Bcl-2 expression and the degree of histological differentiation (Phi=-0.850, p=< 0.0001). Finally, Bcl-2 expression was also inversely associated with the pN stage of the lymph nodes (p=0.001). Conclusion: Considering the association of Bcl-2 expression with the expression of genes that are related to therapy prediction (ER and PR) it remains to be ascertained whether Bcl-2 could be used as a potential predictive marker. Moreover, the negative association of Bcl-2 with Ki67 and HER2 should be furthermore investigated for its association with disease outcome and response to targeted therapy. Meanwhile, the observed association of immunohistochemical Bcl-2 expression with clinicopathological characteristics which are known prognositc indicators for breast cancer (grade and pN stage) provides confirmatory evidence to the potential important prognostic value of this marker in breast cancer. Overall, this study suggests that Bcl-2 should be further tested for its incorporation into a multivariate prediction model for breast cancer therapy. In addition, more investigations are required into targeted anti-Bcl-2 therapy may be used to modify responses to current breast cancer therapy, in order to reduce resistance.
Degree
thesis:*- Grantor dc:publisher
- University of West Attica
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Konstantinidi, Paraskevi
- Κωνσταντινίδη, Παρασκευή
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60409